NanoString Showcases Groundbreaking Body of Research at the 2018 Annual Meeting of the American Association for Cancer Research
12 avr. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, April 12, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Announces Launch of Breast Cancer 360 Research Panel, Expanding the 360 Series of Cancer Panels for Translational Research and Signature Development
10 avr. 2018 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString to Release First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018
09 avr. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, April 09, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Technologies Releases Fourth Quarter and Full Year 2017 Operating Results and Provides 2018 Outlook
07 mars 2018 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, March 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported...
NanoString to Present at the 38th Annual Cowen Healthcare Conference
06 mars 2018 16h05 HE
|
NanoString Technologies, Inc.
SEATTLE, March 06, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018
21 févr. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Feb. 21, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference
12 févr. 2018 06h00 HE
|
NanoString Technologies, Inc.
Digital Spatial Profiling Demonstrates Profiling of Proteins and 1,000+ mRNAs Across Multiple Regions from FFPE Tissue Sections using Next Generation Sequencing Readout First Customer Data Using...
NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
05 févr. 2018 16h01 HE
|
NanoString Technologies, Inc.
Comprehensive Study Includes All Danish Women Diagnosed with Breast Cancer from 2000 to 2003 who were Indicated for Prosigna and Treated with Endocrine Therapy Accompanying Editorial Highlights...
NanoString Reports Inducement Grant Under NASDAQ Listing Rules
19 janv. 2018 21h18 HE
|
NanoString Technologies, Inc.
SEATTLE, Jan. 19, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported,...
NanoString Appoints Thomas Bailey as Chief Financial Officer
16 janv. 2018 09h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...